Background: Stress ulcer is a severe complication in critically ill patients and causes a high mortality. The proton pump inhibitor esomeprazole is widely applied in the treatment of stress ulcers because of its powerful acid suppression ability. However, the mechanism of stress ulcer and the precise gastroprotective effect of esomeprazole in stress ulcer remain unclear. Purpose: In the present study, the rats with water-immersed and restraint (WIR)-induced stress ulcer were used to further elucidate the anti-ulcerogenic capacity of esomeprazole in stress ulcer in addition to its anti-acid secreting ability. Methods and results: The rats were randomly divided into 5 groups: control group (NS), water-immersed and restraint group (WIR), high-dose application of esomeprazole plus stress ulcer-induced group (HE+WIR), low-dose application of esomeprazole plus stress ulcer-induced group (LE+WIR), and high-dose application of esomeprazole without stress ulcer-induced group (HE). Our study showed that the pretreatment of esomeprazole alleviated gastric tissue damage in both macroscopic and histopathological manifestations. Pretreatment of esomeprazole elevated the decline in PEG2 level affected by WIR; and it inhibited the secretion of gastric acid, gastrin and pepsin. Moreover, esomeprazole exerted its antioxidant effects by reducing malondialdehyde levels, enhancing the expressions of antioxidant factors like glutathione and superoxide dismutase (SOD) and reducing the compensatory transcriptional elevation of SOD1 gene. Esomeprazole also reduced the levels of MPO (myeloperoxidase), tumor necrosis factor (TNF)-α and interleukin (IL)-1β according to its anti-inflammatory effects. We further explored the possible mechanism of esomeprazole pretreatment on stress ulcer and demonstrated that esomeprazole attenuated the high phosphorylation levels of nuclear factor kappa B (NF-κB) p65 and p38 MAPK, and decreased the NF-κB p65 nuclear translocation induced by WIR related stress ulcer. Conclusion: Our study provides some evidence that the esomeprazole pretreatment exerts gastroprotective effects in WIR-induced stress ulcer through not only its antisecretory effect but also its antioxidant effect by inactivating the p38 MAPK and NF-κB signaling pathways.
Malignant nasopharyngeal diseases, particularly nasopharyngeal carcinoma, are challenging to detect due to their non-specific symptoms, the anatomical location of the nasopharynx and the lack of cost-effective routine screening methods.1 Consequently, over 70% of nasopharyngeal carcinoma cases are diagnosed at advanced stages (III or IV) during the initial presentation,2 with a 5-year overall survival of about 50%. However, when nasopharyngeal carcinoma is detected at early stages, the 5-year overall survival approaches 95% or higher.3 4 The current diagnostic gold standards—rhinolaryngoscopy and transnasal gastroscopy with histological examination—are unsuitable for routine screening due to their lack of cost-effectiveness and, as diagnostic tools, suffer from technical limitations such as image sensor size, optical fibre count, field of view and lack of magnification capability, which significantly reduce image quality.5 6 Upper GI gastroscopy, one of the most commonly performed diagnostic procedures, is the standard method for diagnosing various GI diseases and is used for screening in some high-risk areas for oesophageal or gastric cancer.7 8 Studies have demonstrated that systematic assessment of the pharynx during gastroscopy can enhance the detection of pre-cancerous and incidental otolaryngologic lesions.9 10 However, it was previously thought that the nasopharynx could not be visualised during upper GI endoscopy unless a nasal entry was performed.11 Since most malignant nasopharyngeal diseases occur …